Treatment of cystoid macular edema with the new-generation NSAID nepafenac 0.1%

PURPOSE: To describe the use of nepafenac 0.1% for cystoid macular edema (CME). METHODS: This was a multicenter retrospective review of 22 CME cases (20 patients) treated with nepafenac 0.1% (six with concomitant prednisolone acetate 1%) from December 2005 to April 2008: three acute pseudophakic CME...

Descripción completa

Detalles Bibliográficos
Autores principales: Hariprasad, Seenu M, Akduman, Levent, Clever, Joseph A, Ober, Michael, Recchia, Franco M, Mieler, William F
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2709014/
https://www.ncbi.nlm.nih.gov/pubmed/19668559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2709014/
https://www.ncbi.nlm.nih.gov/pubmed/19668559

Ejemplares similares